Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Pharmacorp Rx Inc. ( (TSE:PCRX) ) is now available.
PharmaCorp Rx Inc. has filed a preliminary short form base shelf prospectus in Canada, excluding Quebec, allowing the company to distribute up to $100 million in various securities over a 25-month period. This move is intended to provide the company with the flexibility to access capital markets efficiently, supporting its growth and acquisition strategy, particularly through its strategic alliance with PharmaChoice Canada.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian company focused on acquiring and operating pharmacies, empowering pharmacists as equity partners, and supporting succession for retiring pharmacy owners. The company operates under the PharmaChoice Canada banner and aims to build a national network of community pharmacies across Canada.
Average Trading Volume: 25,659
Technical Sentiment Signal: Sell
Current Market Cap: C$49.74M
For an in-depth examination of PCRX stock, go to TipRanks’ Overview page.